Upcoming Events and Webinars

Past Webinars


Precision Oncology Roundtable: Ask the Experts about NGS-based Tumor Profiling

October 12, 2017

Featuring Speakers from:

Dartmouth-Hitchcock
Augusta University
Moffitt Cancer Center

This webinar was an interactive roundtable discussion on the adoption of a commercial gene panel for tumor profiling at several leading US cancer centers.

Our expert panel — Gregory Tsongalis from Dartmouth-Hitchcock, Anthony Magliocco from Moffitt Cancer Center, Ravindra Kolhe from Augusta University, and Rakesh Nagarajan from PierianDx — will specifically discuss their experiences with Illumina’s TruSight Tumor 170 targeted cancer assay.

The TST170 next-generation sequencing-based panel targets single nucleotide variants, indels, gene amplifications, gene fusions, splice variants, mRNA expression, and mRNA isoform detection found in 170 cancer-related genes and also calculates metrics such as tumor mutation burden and determines evidence for microsatellite instability.

Our panelists will discuss the design of the assay, data analytics, and reasons behind their selection of the TST170 assay, and will share details of how it is being utilized within their organizations.

Watch Recorded Webinar


Clinical Genomicist Workspace (CGW): Accelerate Your NGS Testing with an End-to-End Integrated Workspace

September 28, 2017

PierianDx accelerates precision medicine by offering one space to handle a range of genomic testing, from somatic to constitutional, from small panels to whole exome or genome. During this webinar, PierianDx Chief Biomedical Informatics Officer Dr. Rakesh Nagarajan will provide an overview of CGW and illustrate how the industry leading platform seamlessly manages genomic data and workflow for each case, from variant analysis and classification to interpretation, reporting and final sign out. Nagarajan will discuss:

  • An overview of CGW key features and functions

  • How PierianDx’s knowledgebase helps to deliver clinically actionable results by leveraging millions of biomedical findings across multiple databases to analyze and classify each detected variant

  • Examples of actionable clinical reports, both somatic and constitutional

  • Customer case studies and how CGW has accelerated NGS testing programs, streamlined lab efficiencies and ultimately improved patient care

Watch Recorded Webinar


Building a Best-in-Class Precision Medicine Program: The Moffitt Cancer Center Story

September 14, 2017

Building a world-class precision medicine program takes the right mix of innovative leadership, advanced technology, clinical acumen, and strategic partnerships. During this webinar, Dr. Anthony Magliocco, the Chair of Anatomic Pathology at Moffitt Cancer Center, will share the Moffitt success story – from its pioneering inception to being one of only 47 Comprehensive Cancer Centers as designated by the National Cancer Institute.
Dr. Magliocco will discuss:

  • Key variables that played an important part in Moffitt Cancer Center’s evolution.

  • The role of the state-of-the-art Morsani Molecular Diagnostics Laboratory played in that evolution

  • Pathways to success, unexpected barriers, and an in-depth review of what steps were taken to ensure that the patient comes first

  • A blueprint for other clinical labs seeking to accelerate precision medicine and NGS testing

Watch Recorded Webinar


Taking Your NGS Testing Program to the Next Level with Enhanced Validation and Interpretation Services

July 13, 2017 at 11:00am CST

The success of any precision medicine program involves the right combination of personnel and technology. PierianDx’s Clinical Genomicist Workspace (CGW) has been the technology platform of choice for clinical labs to seamlessly manage their genomic data and workflow from variant analysis and classification to interpretation, reporting and final sign out. However, the right strategy and clinical resources at the validation and interpretation stages are just as important to that success. During this webinar, PierianDx Chief Bioinformatics Officer Rakesh Nagarajan will discuss ways clinical labs can improve validation and interpretation approaches to enhance report actionability, relevance and throughput. Specifically, Nagarajan will discuss:

  • Guidelines for improved test validation covering a range of examples

  • Various validation reports, covering a range of different assays

  • Understanding the different roles of automated interpretation and clinical interpretation utilizing genomic scientists and medical directors

  • Case studies of customers who have enhanced their clinical lab capability with PierianDx validation and interpretation services

Watch Recorded Webinar


Accelerating Your NGS Testing Program: Examples and Case Studies

On March 9th, Clinical Genomicist Workspace user and Partner Sharing Network contributor, Dr. Nikoletta Sidiropoulos from University of Vermont Medical Center hosted a webinar with PierianDx exploring various ways clinical labs have established or expanded their NGS testing programs by implementing improved workflow and clinical integration into their organization. Dr. Sidiropoulos shared her experiences and lessons learned as she works to evolve the university’s precision medicine program. Specific examples were shared on how to improve clinical lab workflow, starting with DNA or RNA samples and ending with a report of relevant variants to assist in clinical decision-making. By the end of this webinar, participants will have some real-world examples of how to accelerate their own personalized medicine initiatives from clinical experts in the field.

Watch Recorded Webinar


NGS Roundtable: Ask the Experts about the Future of Clinical NGS Testing

This interactive roundtable discusses established and emerging regulatory, scientific, and medical topics related to next-generation sequencing in the clinical setting. An expert panel of leading pathologists, medical geneticists, and researchers will address genomic testing advances in two thematic areas: 1) scientific and clinical trends in reporting, and 2) clinical lab operations and quality management.

Topics covered by the expert panel include the importance of proficiency testing, both from the regulatory and quality perspective, and technical and clinical advances in using NGS to predict effective immunotherapy and determine tumor mutation load.

Watch Recorded Webinar


Recent News


PierianDx Names New Additions to Sales and Clinical Genomic Solutions Teams

October 26, 2017
PierianDx announced today two key additions that will expand the organization’s reach into health systems and global markets while deepening
Read More

Cleveland Clinic Joins PierianDx’s Customer Network to Accelerate Precision Medicine

October 17, 2017
PierianDx announced today that Cleveland Clinic will utilize its integrated “one space” workflow and analysis solution, Clinical Genomicist Workspace (CGW),
Read More

PierianDx Accelerates Precision Medicine with Fully Integrated Workflow and Interpretation Solution Supporting Illumina TruSight Tumor 170

October 11, 2017
PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today it has launched a complete technology and medical
Read More

PierianDx Announces Clinical Microarray Technology Will Be Integrated into its End-to- End Genomics Platform for Clinical Labs

September 21, 2017
ST LOUIS  – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that its leading, integrated “one space” genomics workflow
Read More

Moffitt Cancer Center Showcases its Blueprint for Building a Best-in-Class Precision Medicine Program at PierianDx-hosted Webinar

September 11, 2017
PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, will host a webinar featuring Moffitt Cancer Center’s journey to
Read More

PierianDx Announces Launch of Clinical Interpretation Services at ACMG 2017

March 23, 2017
New Service Combines Powerful Technology with Medical and Scientific Expertise PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced
Read More

PierianDx Customers Cite ‘Creative Partnership’ on Clinical Genomics as Key Selling Point

March 13, 2017
NEW YORK (GenomeWeb) – Last week, PierianDx announced six new customers for its Clinical Genomicist Workspace (CGW), including Cedars-Sinai Medical
Read More

PierianDx’s Partner Sharing Network Achieves Critical Mass with New Wave of Customers Adopting Clinical Genomicist Workspace (CGW)

March 3, 2017
PierianDx announced today that six leading healthcare systems and academic medical centers have chosen its leading “One Space” genomics software
Read More

University of Vermont Touts the Importance of Clinical Integration to Accelerate Precision Medicine in PierianDx Webinar Series

February 28, 2017
PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today its latest online webinar entitled, “Accelerating Your NGS
Read More

Doctors Use Computers More and Microscopes Less to Find Future Cancer Treatments

December 6, 2016
Not long ago, doctors hoping to cure human disease spent a lot of time in the laboratory looking through microscopes.
Read More

PierianDx Acquires Tute Genomics

October 11, 2016
Company Extends Ability to Deliver a Unified Sample-to-Report Software Platform for Clinical Labs PierianDx, the forerunner in clinical genomic analysis, interpretation
Read More

PierianDx Named to CIOReview’s 20 Most Promising Cloud Solution Providers 2016

August 30, 2016
ST LOUIS – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, was recently included in a list of
Read More

PierianDx and ArcherDX Announce Partnership Benefiting NGS Clinical Labs

July 19, 2016
ST LOUIS/BOULDER – ArcherDX and PierianDx today announced co-marketing and licensing agreements that will provide enhanced NGS testing capabilities to
Read More

PierianDx Announces 10 New Customers in Q1 2016, Expands Partner Sharing Network to 24 Members

April 28, 2016
ST. LOUIS, MO  – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced it has added several new
Read More

PierianDx Announces Two New Board Members; Bryan Carey and Frederick Hessler Bring Vast Healthcare Experience

March 22, 2016
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that Bryan J. Carey and
Read More

PierianDx Closes Series A Financing Led by Health Catalyst Capital Management; Company Poised for Next Stage of Growth

January 7, 2016
PierianDx, the leading provider of genomic software and services to enable data-driven personalized medicine, announced that it closed $9.25 million in Series A financing
Read More

PierianDx and Syapse Partner to Accelerate Precision Medicine Programs for Healthcare Providers

October 29, 2015
ST. LOUIS, MO and PALO ALTO, CA – PierianDx, makers of the leading bioinformatics platform for clinical genomics testing, and
Read More

Aeon Clinical Laboratories Leverages PierianDx Bioinformatics Platform to Enhance Genomic Test Offering

October 13, 2015
ST LOUIS, MO/GAINSVILLE, GA – PierianDx, the forerunner in clinical genomic informatics, and Aeon Clinical Laboratories, one of the fastest
Read More

MDL Partners with PierianDx to Rapidly Launch Next Generation Sequencing Tests for Breast Cancer

August 25, 2015
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that Molecular Diagnostics Laboratories (MDL) has standardized
Read More

PierianDx Launches Exome Next Generation Sequencing Offering; Leading Medical Experts Shape Platform Functionality

August 13, 2015
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that it has released a new version
Read More

PierianDx Builds Leadership Team to Accommodate Fast Growth Jim Howard Joins as Senior VP Sales

April 23, 2015
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that healthcare entrepreneur Jim Howard is joining
Read More

PierianDx Plans Software Update to Improve Variant Prioritization, Clinical Relevance Assessment

April 2, 2015
NEW YORK (GenomeWeb) – This summer, PierianDx plans to add a so-called PDx score to the next iteration of Clinical
Read More

PierianDx Introduces PDx Score to Quickly Prioritize Actionable Variants, While Expanding Industry-Leading Knowledgebase

March 24, 2015
ST LOUIS, MO –  PierianDx announced today that its genomic testing platform will soon produce a PDx Score giving clinicians
Read More

UVA to use PierianDx Platform to Analyze, Report on Cancer Patients’ Genome Data

February 23, 2015
ST LOUIS, MO and CHARLOTTESVILLE, VA – PierianDx announced today that the University of Virginia Health System has joined the
Read More

Inova Joins PierianDx Partner Network to Provide Precision Medicine to Cancer Patients

February 19, 2015
ST LOUIS, MO and FALLS CHURCH, VA – PierianDx announced today that the Inova Translational Medicine Institute has joined the
Read More

ARUP Introduces NGS.Web, a Powerful Next-Generation Sequencing Platform

January 21, 2015
January 21, 2015—ARUP Laboratories, a national nonprofit reference laboratory, announced today the implementation of NGS.Web, a powerful next-generation sequencing (NGS) platform. This innovative platform will enhance sample tracking, data analysis, and reporting of genetic and oncological sample testing.
Read More

PierianDx Launches NGS Gateway Program

November 17, 2014
PierianDx, the forerunner in clinical genomic informatics, announced the PDX NGS Gateway Program, a service designed to enable partner personalized medicine initiatives.
Read More

PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan publishes article describing laboratory standards for Clinical Next-Generation Sequencing

September 2, 2014
PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan publishes article describing laboratory standards for Clinical Next-Generation Sequencing. College of American Pathologists’
Read More

PierianDx Launches the Clinical Genomicist Workstation for SaaS NGS Analysis

July 23, 2014
By Allison Proffitt, Clinical Informatics News Washington University is throwing its hat in the clinical sequencing ring with a...
Read More

Moffitt Cancer Center and the University of Vermont Join PierianDx Partner Network

July 17, 2014
ST LOUIS – PierianDx announced today that Moffitt Cancer Center in Tampa, FL and Fletcher Allen...
Read More

PierianDx Licenses Diagnostic Genetic Sequencing Products from Washington University in St. Louis

June 30, 2014
ST. LOUIS, MO – PierianDx announced today that it has exclusively licensed from Washington University in St. Louis a proprietary
Read More

Journal of Molecular Diagnostics

June 1, 2014
PierianDx Medical Advisor, Catherine Cottrell, Ph.D., FACMG, publishes an article in the Journal of Molecular Diagnostics describing the validation and
Read More

Clinical NGS WUSTL

January 1, 2014
Rakesh Nagarajan, M.D., PhD., PierianDx Founder and Chief BioMedical Informatics Officer presents at the Cancer Informatics for Cancer Centers Spring 2014 Conference at the Meritage Conference Center in Napa Valley, California.
Read More